Mycoplasma Pneumoniae from the Respiratory Tract and Beyond

Overview

Journal Clin Microbiol Rev

Publisher American Society for Microbiology

Specialty Microbiology

Date 2017 May 26

PMID 28539503

Citations 289

Authors

Ken B Waites

Li Xiao

Yang Liu

Mitchell F Balish

T Prescott Atkinson

Affiliations

Soon will be listed here.

Abstract

is an important cause of respiratory tract infections in children as well as adults that can range in severity from mild to life-threatening. Over the past several years there has been much new information published concerning infections caused by this organism. New molecular-based tests for detection are now commercially available in the United States, and advances in molecular typing systems have enhanced understanding of the epidemiology of infections. More strains have had their entire genome sequences published, providing additional insights into pathogenic mechanisms. Clinically significant acquired macrolide resistance has emerged worldwide and is now complicating treatment. susceptibility testing methods have been standardized, and several new drugs that may be effective against this organism are undergoing development. This review focuses on the many new developments that have occurred over the past several years that enhance our understanding of this microbe, which is among the smallest bacterial pathogens but one of great clinical importance.

Citing Articles

Antibiotic resistance and viral co-infection in children diagnosed with pneumonia caused by Mycoplasma pneumoniae admitted to Russian hospitals during October 2023-February 2024.

Korneenko E, Rog I, Chudinov I, Lukina-Gronskaya A, Kozyreva A, Belyaletdinova I BMC Infect Dis. 2025; 25(1):363.

PMID: 40089690 DOI: 10.1186/s12879-025-10712-0.

Neutrophils are involved in the development and outcomes of plastic bronchitis associated with Mycoplasma pneumoniae pneumonia.

Huang X, Qin H, Zhang R, Jia X, Zhao D, Liu F Respir Res. 2025; 26(1):92.

PMID: 40057734 PMC: 11890523. DOI: 10.1186/s12931-025-03167-z.

P1 adhesin genotype characteristics of in China from 2017 to 2019.

Li S, Dou H, Shi D, Yuan R, Tu P, Yuan Q Front Cell Infect Microbiol. 2025; 15:1513177.

PMID: 40034391 PMC: 11872919. DOI: 10.3389/fcimb.2025.1513177.

Macrolide-Resistant Mycoplasma pneumoniae Infections among Children after COVID-19 Pandemic, Ohio, USA.

Leber A, Embry T, Everhart K, Taveras J, Oyeniran S, Wang H Emerg Infect Dis. 2025; 31(3):555-558.

PMID: 40023809 PMC: 11878328. DOI: 10.3201/eid3103.241570.

Prevalence and distribution of respiratory pathogens in pediatric acute respiratory infections in Putian, China.

Zhu J, Wu S, Chen Y, Zheng L BMC Infect Dis. 2025; 25(1):278.

PMID: 40012061 PMC: 11863460. DOI: 10.1186/s12879-025-10670-7.

References

Qu J, Yu X, Liu Y, Yin Y, Gu L, Cao B . Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility. PLoS One. 2013; 8(12):e82174. PMC: 3867324. DOI: 10.1371/journal.pone.0082174. View

Nir-Paz R, Abutbul A, Moses A, Block C, Hidalgo-Grass C . Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012. Euro Surveill. 2012; 17(8). View

Martin R, Kraft M, Chu H, Berns E, Cassell G . A link between chronic asthma and chronic infection. J Allergy Clin Immunol. 2001; 107(4):595-601. DOI: 10.1067/mai.2001.113563. View

Spuesens E, Hoogenboezem T, Sluijter M, Hartwig N, van Rossum A, Vink C . Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J Microbiol Methods. 2010; 82(3):214-22. DOI: 10.1016/j.mimet.2010.06.004. View

Loens K, Van Heirstraeten L, Malhotra-Kumar S, Goossens H, Ieven M . Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections. J Clin Microbiol. 2008; 47(1):21-31. PMC: 2620840. DOI: 10.1128/JCM.02037-08. View

Esposito S, Bosis S, Begliatti E, Droghetti R, Tremolati E, Tagliabue C . Acute tonsillopharyngitis associated with atypical bacterial infection in children: natural history and impact of macrolide therapy. Clin Infect Dis. 2006; 43(2):206-9. DOI: 10.1086/505120. View

Lucier T, Heitzman K, Liu S, Hu P . Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother. 1995; 39(12):2770-3. PMC: 163027. DOI: 10.1128/AAC.39.12.2770. View

Liu F, Chen P, Huang F, Tsai C, Lee C, Lin C . Do serological tests provide adequate rapid diagnosis of Mycoplasma pneumoniae infection?. Jpn J Infect Dis. 2008; 61(5):397-9. View

Krivan H, Olson L, Barile M, Ginsburg V, Roberts D . Adhesion of Mycoplasma pneumoniae to sulfated glycolipids and inhibition by dextran sulfate. J Biol Chem. 1989; 264(16):9283-8. View

10.

Unemo M, Dillon J . Review and international recommendation of methods for typing neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin Microbiol Rev. 2011; 24(3):447-58. PMC: 3131056. DOI: 10.1128/CMR.00040-10. View

11.

Kannan T, Hardy R, Coalson J, Cavuoti D, Siegel J, Cagle M . Fatal outcomes in family transmission of Mycoplasma pneumoniae. Clin Infect Dis. 2011; 54(2):225-31. PMC: 3245726. DOI: 10.1093/cid/cir769. View

12.

Salvatore C, Fonseca-Aten M, Katz-Gaynor K, Gomez A, Mejias A, Somers C . Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infect Immun. 2006; 75(1):236-42. PMC: 1828434. DOI: 10.1128/IAI.01249-06. View

13.

Weng W, Peng S, Wang S, Chou Y, Lee W . Mycoplasma pneumoniae--associated transverse myelitis and rhabdomyolysis. Pediatr Neurol. 2009; 40(2):128-30. DOI: 10.1016/j.pediatrneurol.2008.10.009. View

14.

Busson L, van den Wijngaert S, Dahma H, Decolvenaer M, Di Cesare L, Martin A . Evaluation of 10 serological assays for diagnosing Mycoplasma pneumoniae infection. Diagn Microbiol Infect Dis. 2013; 76(2):133-7. PMC: 7127255. DOI: 10.1016/j.diagmicrobio.2013.02.027. View

15.

Lin J, Lin K, Chiu C, Hsia S, Wang H, Chou I . Antineuronal antibodies and infectious pathogens in severe acute pediatric encephalitis. J Child Neurol. 2012; 29(1):11-6. DOI: 10.1177/0883073812461944. View

16.

Yan C, Sun H, Lee S, Selvarangan R, Qin X, Tang Y . Comparison of Molecular Characteristics of Mycoplasma pneumoniae Specimens Collected from the United States and China. J Clin Microbiol. 2015; 53(12):3891-3. PMC: 4652102. DOI: 10.1128/JCM.02468-15. View

17.

Pritchard R, Prassinos A, Osborne J, Raviv Z, Balish M . Reduction of hydrogen peroxide accumulation and toxicity by a catalase from Mycoplasma iowae. PLoS One. 2014; 9(8):e105188. PMC: 4134286. DOI: 10.1371/journal.pone.0105188. View

18.

Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N . Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000; 28(12):E63. PMC: 102748. DOI: 10.1093/nar/28.12.e63. View

19.

Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K . Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrob Agents Chemother. 2004; 48(12):4624-30. PMC: 529214. DOI: 10.1128/AAC.48.12.4624-4630.2004. View

20.

Diaz M, Cross K, Benitez A, Hicks L, Kutty P, Bramley A . Identification of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis. 2016; 3(2):ofw071. PMC: 4867659. DOI: 10.1093/ofid/ofw071. View